Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer

Richard S. Foster*, Jack Baniel, Ilan Leibovitch, Michael Curran, Richard Bihrle, Randall Rowland, John P. Donohue

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

Purpose: We determined whether teratomatous elements in the orchiectomy specimen predict for teratoma in the retroperitoneum in patients who have not received chemotherapy. Materials and Methods: We retrospectively reviewed the records of patients with clinical stages A, B and B2 nonseminoma who underwent retroperitoneal lymph node dissection. Results: Teratomatous elements in the orchiectomy specimen predict for retroperitoneal teratoma. Conclusions: When deciding on treatment for low stage nonseminoma, the presence or absence of teratoma in the orchiectomy specimen should be considered to minimize double therapy.

Original languageEnglish
Pages (from-to)1943-1945
Number of pages3
JournalJournal of Urology
Volume155
Issue number6
DOIs
StatePublished - Jun 1996
Externally publishedYes

Keywords

  • Neoplasm metastasis
  • Teratoma
  • Testicular neoplasms
  • Testis

Fingerprint

Dive into the research topics of 'Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer'. Together they form a unique fingerprint.

Cite this